Ignite Creation Date:
2024-05-05 @ 4:38 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00283725
Status:
COMPLETED
Last Update Posted:
2013-01-25
First Post:
2006-01-27
Brief Title:
Use of Different Treatment Care Methods in Patients With Dementia Associated With Alzheimers Disease
Sponsor:
Ortho-McNeil Neurologics Inc
Organization:
Ortho-McNeil Neurologics Inc
Study Overview
Official Title:
Review of Management Strategies in Dementia
Status:
COMPLETED
Status Verified Date:
2013-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
REMIND
Brief Summary:
The purpose of this observational study is to examine patterns of treatment care for patients with Alzheimers disease AD in a real-world arena and to examine the association with different outcomes for patients and informal caregivers
Detailed Description:
This is a 2-year multicenter prospective look forward using periodic observations collected predominantly following patient enrollment longitudinal it is a co relational research study that involves repeated observations of the same variables over long periods of time and observational study The objective of this study is to examine the patients with mild and moderate AD who are currently being treated with different treatment care methods in real-world settings Doctors will not be provided medication or asked to treat their patients with any particular treatment The effect of the different management strategies on cognition activities of daily living and behavior of the patients will be evaluated and data on the informal caregiver burden will be assessed Data on the utilization of health and social care services by the patient and the primary informal caregiver including admission of the patient to an assisted living facility or nursing home will be assessed The doctors assessment of clinical global impression and adverse events will also be documented Data will be collected from the doctors at baseline and at 6 12 and 24 months and from the caregivers at baseline and 6 12 18 and 24 months The medication dosage and administration is based upon the doctors prescription individualized for the patient and not dictated by the protocol
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| GAL-OUT-065 | OTHER | Ortho-McNeil Neurologics Inc | None |
| GALALZ4004 | OTHER | None | None |